DEUTSCHE BANK AG\ - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$3,394,000
+68.6%
998,823
+86.4%
0.00%0.0%
Q2 2018$2,013,000
+61.7%
535,791
+75.8%
0.00%0.0%
Q1 2018$1,245,000
+30.2%
304,722
+48.0%
0.00%0.0%
Q4 2017$956,000
+33.1%
205,933
+103.2%
0.00%
Q3 2017$718,000
+1.1%
101,348
+3.0%
0.00%
-100.0%
Q2 2017$710,000
+400.0%
98,376
+321.4%
0.00%
Q1 2017$142,000
-59.8%
23,344
-61.4%
0.00%
Q4 2016$353,000
-59.6%
60,505
-63.3%
0.00%
-100.0%
Q3 2016$873,000
-14.6%
164,862
+6.6%
0.00%0.0%
Q2 2016$1,022,000
+942.9%
154,695
+623.6%
0.00%
Q1 2016$98,000
-59.2%
21,379
-55.4%
0.00%
Q4 2015$240,000
-80.1%
47,973
-86.0%
0.00%
-100.0%
Q3 2015$1,205,000
-30.3%
342,802
+97.6%
0.00%0.0%
Q2 2015$1,728,000
+99.1%
173,503
+153.5%
0.00%0.0%
Q1 2015$868,000
-72.3%
68,435
-69.1%
0.00%
-50.0%
Q4 2014$3,129,000
-6.9%
221,387
-9.6%
0.00%0.0%
Q3 2014$3,361,000
+267.7%
244,776
+310.7%
0.00%
+100.0%
Q2 2014$914,000
-27.3%
59,595
-19.3%
0.00%0.0%
Q1 2014$1,258,000
+11.4%
73,865
-15.4%
0.00%0.0%
Q4 2013$1,129,000
-87.7%
87,337
-90.4%
0.00%
-85.7%
Q3 2013$9,182,000910,1950.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders